Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.
Renergen has confirmed ongoing LNG production and helium liquefaction at its Phase 1 plant, addressing recent share price volatility and outlining plans to boost capacity through additional wells.